Pricing Log in Create free account

Brainstorm Cell Therapeutics Inc. (BCLI) vs Kiora Pharmaceuticals, Inc. (KPRX)

Brainstorm Cell Therapeutics Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Brainstorm Cell Therapeutics Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($7.0M and $6.6M). Across the 10 metrics below, Brainstorm Cell Therapeutics Inc. leads on 7 and Kiora Pharmaceuticals, Inc. on 3.

Valuation

Metric BCLI KPRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.47 9.40
P/B n/m 0.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.62 0.66
EV/Sales n/m (0.42) 9.02
Earnings yield (103.48%) (174.20%) (32.88%)
Free cash flow yield (40.91%) (98.19%) (23.13%)

Profitability

Metric BCLI KPRX Biotechnology median
Gross margin 0.00% 85.06% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 119.20% (56.36%) (51.96%)
Return on assets (627.43%) (39.43%) (46.06%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric BCLI KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 6.76%
EPS growth (last fiscal year) 51.95% (403.45%) 29.88%
Revenue growth, 5-year CAGR — 88.72% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCLI KPRX Biotechnology median
Debt to equity (0.11) 0.00 0.00
Current ratio 0.03 8.97 4.97
Net debt to EBITDA (0.10) 1.33 1.01

Dividend

Metric BCLI KPRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCLI KPRX Biotechnology median
Market cap 6.99m 6.63m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack